TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
XLO

Xilio Development Inc

Healthcare · Biotechnology

8.90$ -1.2% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement XLO
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – 100.0% 100.0%
– – – – – 25.9% 3.5%
– – – – – 100.0% 96.5%
– – – – – 649.6% 128.0%
– – – – – 390.6% 67.9%
– – – – – 1,054.9% 192.4%
– – – – – -954.9% -95.9%
– – – – – 1.6% –
– – – – – -918.0% -80.1%
– – – – – -918.0% -80.1%
– – – – – -914.3% -76.5%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?